menu
    • menu

    Company profile for Glympse bio

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2015, Glympse Bio is an MIT spin-out from the laboratory of renowned bioengineer, Dr. Sangeeta Bhatia. Glympse Bio is headquartered in Cambridge, MA. Our team is committed to enhancing our understanding of human disease. Our goal is to better serve the needs of patients, clinicians, researchers, drug developers, and payors. We are pioneering the development of synthetic biomarkers – biological sensors developed us...
    Founded in 2015, Glympse Bio is an MIT spin-out from the laboratory of renowned bioengineer, Dr. Sangeeta Bhatia. Glympse Bio is headquartered in Cambridge, MA. Our team is committed to enhancing our understanding of human disease. Our goal is to better serve the needs of patients, clinicians, researchers, drug developers, and payors. We are pioneering the development of synthetic biomarkers – biological sensors developed using breakthroughs in science, engineering, medicine and artificial intelligence – that are bioengineered to be perfectly tunable to any disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Glympse bioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Main Street Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://glympsebio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/glympse-bio
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/glympsebio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sunbird Bio Merges with Glympse for Proprietary Diagnostic Technologies
    Sunbird Bio Merges with Glympse for Proprietary Diagnostic Technologies

    09 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230809588364/en

    BUSINESSWIRE
    09 Aug 2023
    Share Share
    Glympse Bio names Gilead vet as first chief medical officer
    Glympse Bio names Gilead vet as first chief medical officer

    08 Sep 2021

    // Andrea Park FIERCEBIOTECH

    https://www.fiercebiotech.com/medtech/glympse-bio-names-first-medical-chief-offering-a-peek-at-clinical-future-its-disease

    Andrea Park FIERCEBIOTECH
    08 Sep 2021
    Share Share
    Glympse Bio clears first-in-human study of injectable biosensors
    Glympse Bio clears first-in-human study of injectable biosensors

    16 Nov 2020

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/glympse-bio-clears-first-human-safety-study-its-injectable-biosensors

    Conor Hale FIERCE BIOTECH
    16 Nov 2020
    Share Share
    Gilead-partnered Glympse snares $46.7M for their NASH-snooping biosensors
    Gilead-partnered Glympse snares $46.7M for their NASH-snooping biosensors

    16 Jul 2020

    // Jason Mast ENDPTS

    https://endpts.com/gilead-partnered-glympse-snares-46-7m-for-their-nash-snooping-biosensors/

    Jason Mast ENDPTS
    16 Jul 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search